Yuk, H. D., Jeong, C. W., Kwak, C., Kim, H. H., & Ku, J. H. (2018). Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer? PLoS One.
Citação norma ChicagoYuk, Hyeong Dong, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, and Ja Hyeon Ku. "Should Intravesical Bacillus Calmette–Guerin (BCG) Treatment Be Administered to Patients With T0 After Repeat Transurethral Resection of Bladder Tumor in Patients With High-risk Non-muscle Invasive Bladder Cancer?" PLoS One 2018.
Citação norma MLAYuk, Hyeong Dong, et al. "Should Intravesical Bacillus Calmette–Guerin (BCG) Treatment Be Administered to Patients With T0 After Repeat Transurethral Resection of Bladder Tumor in Patients With High-risk Non-muscle Invasive Bladder Cancer?" PLoS One 2018.